amantadine has been researched along with Chronic Insomnia in 10 studies
amant: an antiviral compound consisting of an adamantane derivative chemically linked to a water-solube polyanioic matrix; structure in first source
| Excerpt | Relevance | Reference |
|---|---|---|
| "Amantadine was reported to decrease serum alanine aminotransferase and HCV RNA levels in chronic hepatitis C patients who had not respond to interferon, but further experience has produced mixed results." | 9.09 | Treatment of chronic hepatitis C patients with amantadine. ( Harada, H; Yagura, M, 2001) |
| "Amantadine hydrochloride is a risky drug for triggering delirium in dialysis patients; however, it is often administered casually." | 8.31 | Amantadine-associated delirium in patients with maintenance dialysis: Insomnia-associated recovery and uneven seasonal distribution. ( Chao, J; He, J; Li, J; Si, B, 2023) |
| "Seventeen patients with choreiform, athetoid, or ballistic involuntary movements, or with spasmodic torticollis, were treated with tetrabenazine in doses of 25 to 200 mg daily for periods varying from two weeks to more than six months." | 7.65 | Treatment of involuntary movement disorders with tetrabenazine. ( Heathfield, KW; Roberts, AH; Swash, M; Zakko, H, 1972) |
| "Amantadine was reported to decrease serum alanine aminotransferase and HCV RNA levels in chronic hepatitis C patients who had not respond to interferon, but further experience has produced mixed results." | 5.09 | Treatment of chronic hepatitis C patients with amantadine. ( Harada, H; Yagura, M, 2001) |
| "Amantadine hydrochloride is a risky drug for triggering delirium in dialysis patients; however, it is often administered casually." | 4.31 | Amantadine-associated delirium in patients with maintenance dialysis: Insomnia-associated recovery and uneven seasonal distribution. ( Chao, J; He, J; Li, J; Si, B, 2023) |
| "Seventeen patients with choreiform, athetoid, or ballistic involuntary movements, or with spasmodic torticollis, were treated with tetrabenazine in doses of 25 to 200 mg daily for periods varying from two weeks to more than six months." | 3.65 | Treatment of involuntary movement disorders with tetrabenazine. ( Heathfield, KW; Roberts, AH; Swash, M; Zakko, H, 1972) |
| " Gross and subtle side effects of amantadine observed in this study on currently recommended dosage are higher than previously reported, which may be an important factor in consideration of mass prophylaxis." | 2.65 | A prospective double-blind study of side effects associated with the administration of amantadine for influenza A virus prophylaxis. ( Bryson, YJ; Monahan, C; Pollack, M; Shields, WD, 1980) |
| "At a 1985 conference on influenza control organised by the US Centers for Disease Control, a major viewpoint expressed was for the routine immunisation of children who are household contacts of high-risk persons." | 1.27 | A perspective on influenza control. ( Imperato, PJ, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (70.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, J | 1 |
| Si, B | 1 |
| Chao, J | 1 |
| He, J | 1 |
| Bryson, YJ | 1 |
| Monahan, C | 1 |
| Pollack, M | 1 |
| Shields, WD | 1 |
| Huete, B | 1 |
| Varona, L | 1 |
| Yagura, M | 1 |
| Harada, H | 1 |
| Imperato, PJ | 1 |
| Birkmayer, W | 1 |
| Galbraith, AW | 1 |
| Oxford, JS | 1 |
| Schild, GC | 1 |
| Watson, GI | 1 |
| Swash, M | 1 |
| Roberts, AH | 1 |
| Zakko, H | 1 |
| Heathfield, KW | 1 |
| Kudashov, NI | 1 |
2 reviews available for amantadine and Chronic Insomnia
| Article | Year |
|---|---|
Use of drugs in the treatment of parkinsonism.
Topics: Amantadine; Depression; Dihydroxyphenylalanine; Feeding and Eating Disorders; Humans; Hypertension; | 1970 |
[Use of amantadine in the prevention and treatment of influenza (review of the literature)].
Topics: Adolescent; Adult; Amantadine; Animals; Chick Embryo; Child; Cycloparaffins; Depression; Female; Hem | 1971 |
3 trials available for amantadine and Chronic Insomnia
| Article | Year |
|---|---|
A prospective double-blind study of side effects associated with the administration of amantadine for influenza A virus prophylaxis.
Topics: Adolescent; Adult; Amantadine; Central Nervous System; Dizziness; Dose-Response Relationship, Drug; | 1980 |
Treatment of chronic hepatitis C patients with amantadine.
Topics: Adult; Aged; Aged, 80 and over; Alanine Transaminase; Amantadine; Antiviral Agents; Cataract; Cognit | 2001 |
Protective effect of 1-adamantanamine hydrochloride on influenza A2 infections in the family environment: a controlled double-blind study.
Topics: Adolescent; Adult; Aged; Amantadine; Child; Child, Preschool; Clinical Trials as Topic; England; Fem | 1969 |
5 other studies available for amantadine and Chronic Insomnia
| Article | Year |
|---|---|
Amantadine-associated delirium in patients with maintenance dialysis: Insomnia-associated recovery and uneven seasonal distribution.
Topics: Amantadine; Delirium; Humans; Renal Dialysis; Retrospective Studies; Seasons; Sleep Initiation and M | 2023 |
[Insomnia during treatment with amantadine].
Topics: Adult; Amantadine; Dopamine Agents; Fatigue; Humans; Male; Multiple Sclerosis; Sleep Initiation and | 1997 |
A perspective on influenza control.
Topics: Adult; Aged; Amantadine; Child; Depression; Female; Health Occupations; Humans; Influenza A virus; I | 1986 |
[Therapeutic strategies and tactics in parkinsonism].
Topics: Amantadine; Antidepressive Agents; Antiparkinson Agents; Benserazide; Carbidopa; Depressive Disorder | 1986 |
Treatment of involuntary movement disorders with tetrabenazine.
Topics: Adolescent; Adult; Aged; Amantadine; Child; Depression; Dystonia Musculorum Deformans; Evaluation St | 1972 |